Dipanjan Pan elected fellow of national medical and biological engineering society

March 27, 2023

By Mary Fetzer

UNIVERSITY PARK, Pa. — The American Institute for Medical and Biological Engineering (AIMBE) has elected a Penn State engineer to its College of Fellows. Dipanjan Pan, Dorothy Foehr Huck & J. Lloyd Huck Chair Professor in Nanomedicine and professor of nuclear engineering and of materials science and engineering, was inducted at the 2023 AIMBE ceremony held March 26-27 in Washington, D.C. Pan is also affiliated with the Department of Biomedical Engineering and with the Huck Institutes.

“Dr. Pan has dedicated his career to finding novel solutions to complex medical problems,” said Jean Paul Allain, Huck Chair Professor and Head of the Ken and Mary Alice Lindquist Department of Nuclear Engineering at Penn State. “His innovative leadership in the field and his dedication to training the next generation of engineers make him truly deserving of this honor.”

Through his research, Pan aims to understand and create defined materials for molecular imaging, drug delivery and non-viral gene delivery applications with a focus on structure, function and engineering processes. His lab is also dedicated to developing immuno-nanomedicine approaches to cancer and other biomedical problems. The translatable technologies developed in Pan’s lab have been licensed 11 times and led to the formation of multiple startups.

"This award is a great honor for me,” said Pan, who is also an elected fellow of the Royal Society of Chemistry, the American Heart Association and the American College of Cardiology and a senior member of the National Academy of Innovators. “Induction into the AIMBE College of Fellows demonstrates my group's continued leadership in biomedical research. It would not have been possible without the contributions from my team: my current and former students, postdocs and scientists from my lab. The support of my collaborators is also greatly appreciated.”

AIMBE is a non-profit society "representing the most accomplished individuals in the fields of medical and biological engineering,” according to the society’s website. Its mission is to advocate for biomedical engineering innovation through public policy initiatives, bringing together academia, industry, government and scientific societies into a highly influential community in medical and biological engineering.

The AIMBE College of Fellows comprises nearly 3,000 individuals in academia, industry, education, clinical practice and government, representing the top 2% of the medical and biological community, according to the AIMBE's website. Fellows are nominated by their peers for significant contributions to medical and biological research and an ability to serve as an advocate for their field and its diversity.

“This recognition of sustained contributions to biomedical research is not an end in itself, but rather a call to continue to engage in meaningful translational research," Pan said.